Home Newsfeeds BTIG Downgrades OncoSec Medical to Neutral

BTIG Downgrades OncoSec Medical to Neutral

BTIG analyst Kaveri Pohlman downgrades OncoSec Medical (NASDAQ:ONCS) from Buy to Neutral.

byBenzinga Newsdesk

November 14, 2022

1 minute read

BTIG analyst Kaveri Pohlman downgrades OncoSec Medical (NASDAQ:ONCS) from Buy to Neutral.

Goldman Sachs Maintains Buy on Becton, Dickinson, Raises Price Target to $319

By Benzinga Newsdesk

August 16, 8:35 AM

Goldman Sachs analyst Amit Hazan maintains Becton, Dickinson (NYSE:BDX) with a Buy and raises the price target from $278 to $319.

BDX

News

Encompass Health Announces Preliminary Plans To Build A 50-Bed Inpatient Rehabilitation Hospital In San Antonio

By Benzinga Newsdesk

April 3, 4:45 PM

Encompass Health Corp. (NYSE:EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital in San Antonio.The hospital, located in Westover Hills, will serve patients recovering

EHC

Netflix Following Amazon-Style Subscriber Tactics? Tests Streaming Deal With France’s Carrefour To Boost Customer Base

By Nabaparna Bhattacharya

January 16, 11:40 AM

Netflix experiments with a potential game-changer, testing a streaming deal with Carrefour to fuel subscriber growth. Inspired by Amazon Prime Video's success, this strategic move aims to offer affordable plans. The trial, initially in Bordeaux and Rouen, includes a €5.99 monthly subscription with added perks like a 10% discount on Carrefour products and free shipping for orders above €60.

AMZN